Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline alfoscerate in elderly patients with type 2 diabetes
NCT03249259Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Mar 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of choline alfoscerate in cognitive impairment, sponsored by Seoul National University Bundang Hospital. Started Mar 2016; status: completed.
02
Drugs
choline alfoscerate
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03249259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249259.